Eledon Pharmaceuticals, Inc. (ELDN)
2.985
-0.02
(-0.83%)
USD |
NASDAQ |
Sep 02, 16:00
2.985
0.00 (0.00%)
After-Hours: 20:00
Eledon Pharmaceuticals Cash from Investing (Quarterly) : 23.24M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.24M |
| March 31, 2026 | 5.956M |
| December 31, 2025 | -20.46M |
| September 30, 2025 | 12.40M |
| June 30, 2025 | 14.96M |
| March 31, 2025 | 3.892M |
| December 31, 2024 | -47.38M |
| September 30, 2024 | -12.80M |
| June 30, 2024 | -19.91M |
| March 31, 2024 | 9.783M |
| December 31, 2023 | 10.08M |
| September 30, 2023 | -25.03M |
| June 30, 2023 | -30.33M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 11.04M |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 23.26M |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.013M |
| September 30, 2016 | -0.002M |
| June 30, 2016 | 0.007M |
| March 31, 2016 | -0.017M |
| December 31, 2015 | -0.316M |
| September 30, 2015 | -15.85M |
| June 30, 2015 | -24.30M |
| March 31, 2015 | -0.045M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | -0.157M |
| June 30, 2014 | -0.006M |
| March 31, 2014 | -0.012M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | -45.80M |
| Viking Therapeutics, Inc. | 109.43M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
| Anika Therapeutics, Inc. | -1.28M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -22.68M |
| Cash from Financing (Quarterly) | 0.091M |
| Free Cash Flow | -73.86M |
| Free Cash Flow Per Share (Quarterly) | -0.1996 |
| Free Cash Flow to Equity (Quarterly) | -22.59M |
| Free Cash Flow to Firm (Quarterly) | -22.68M |
| Free Cash Flow Yield | -26.14% |